| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY |
|---|---|---|---|---|
| Revenue | $210.12M | $195.68M | $169.72M | $228.44M |
| Cost of Revenue | – | – | – | – |
| Gross Profit | – | – | $641.86K | $328.25K |
| Operating Expenses | $205.40M | $189.90M | $168.90M | $222.06M |
| R&D | – | – | – | – |
| SG&A | $19.20M | $17.60M | $28.61M | $32.67M |
| Operating Income | $4.72M | $5.78M | $12.95K | -$355.71K |
| Interest Expense | – | $1.61M | – | – |
| Tax Expense | -$1.88M | $456.77K | $714.40K | $2.18M |
| Net Income | $6.64M | $7.48M | -$8.05M | $3.27M |
| EPS (basic) | 0.1600 | 0.2000 | -0.2200 | 0.1000 |
| EPS (diluted) | 0.1900 | 0.2000 | -0.2200 | 0.1000 |
| Shares (diluted) | $44.88M | $37.26M | $36.25M | $32.68M |